Terry Dagnon - Apr 20, 2023 Form 4 Insider Report for Outlook Therapeutics, Inc. (OTLK)

Role
Chief Operations Officer
Signature
/s/ Lawrence Kenyon, Attorney-in-Fact
Stock symbol
OTLK
Transactions as of
Apr 20, 2023
Transactions value $
-$590,200
Form type
4
Date filed
4/21/2023, 09:05 PM
Previous filing
Apr 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLK Common Stock Sale -$590K -520K -44.33% $1.14 653K Apr 20, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover taxes upon lapse of Issuer's repurchase right as to 75% of the shares as provided in that certain Consulting Agreement dated January 27, 2020.